After inhibiting the activation of PI3K/Akt pathway, the viability of NPC cells in the overexpression group decreased significantly at 48 h and 72 h, while that in the siRNA group increased significantly. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.